跳至主要内容
临床试验/NCT02439034
NCT02439034已完成2 期

Paracetamol With or Without Ketoprofen in the Management of Pain During Hospitalisation and at Home for Patients Receiving Brachytherapy: Phase-2 Randomized Study

Centre Oscar Lambret1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2015年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
68
试验地点
1
主要终点
Level of immediate post-operative pain

研究概览

简要总结

The results of the study will permit to set up a standardized and validated procedure of pain management authorizing medical and paramedical staff of brachytherapy department to handle pain and in this way to improve the quality of life of the patients.

详细描述

  • Selection criteria validation
  • Patient information and collection of a signed informed consent
  • Randomization
  • Completion of HADS questionnaire
  • Day 1 = Begin of analgesic treatment / brachytherapy
  • T-30= 30 minutes before the operative procedure, IV administration of the analgesic treatment (Arm A or B) by the anesthetist
  • T0= end of the operative procedure under general anesthesia
  • T4, T8, and T12 = 4, 8 and 12 hours after T0: evaluation of pain level. If pain level ≥ 4:
  1. paracetamol-codeine (Arms A and B) and continuation of ketoprofen (Arm B). Then, if persistence of pain :
  2. paracetamol and morphine (Arms A and B)
  • Day 2 to Day 30: At home or during hospital stay:

Pain assessment twice a day by the patient until absence of pain during 2 consecutive days

  • Day 3 and Day 15: Pain assessment or phone interview by the algologist of the investigation center ; completion of a HADS questionnaire on Day 3
  • Day 30= End of study: Pain assessment by the algologist of the investigation center and HADS questionnaire

In any case, pain assessment must be done until absence of pain during 2 consecutive days

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient with a uterine cervical cancer or an upper aero-digestive tract cancer
  • •Age ≥ 18 years and ≤ 75 years
  • •Patient who are eligible for brachytherapy treatment associated with or without hospital stay
  • •With operative procedure under general anesthesia to set up the material needed for brachytherapy
  • •Performance status ≤ 2
  • •Creatinine Clearance ≥ 60 ml/min using Cockcroft equation
  • •No coagulation disorder or anticoagulation therapy at curative dose
  • •Registered with a social security system
  • •Patient having dated and signed an informed consent form before initiation of any study procedures

排除标准

  • •Respiratory pathology (SpO2< 70 %)
  • •Severe undernutrition
  • •Previous hypersensitivity reactions such as bronchospasm, asthma, rhinitis, hives or other allergic reaction to ketoprofen, to acetylsalicylic acid, or other NSAIDs
  • •Previous hemorrhage or gastrointestinal perforation during a previous treatment with NSAID
  • •Gastrointestinal hemorrhage , cerebrovascular hemorrhage or other evolutive hemorrhage
  • •Evolutive peptic ulcer, previous peptic ulcer or recurring hemorrhage (2 or more distinct episodes of hemorrhage or ulcer objectified)
  • •Liver insufficiency
  • •Severe renal insufficiency
  • •Severe heart failure
  • •Treatment with another NSAID, including selective cyclooxygenase-2 inhibitors
  • •Intolerance or hypersensitivity to one of the treatments or excipients
  • •Inability to swallow
  • •Pregnant or breastfeeding woman
  • •Patient under tutorship or guardianship

研究组 & 干预措施

Arm A

Active Comparator

Paracetamol

干预措施: Paracetamol (Drug)

Arm B

Experimental

Paracetamol + Ketoprofen

干预措施: Paracetamol (Drug)

Arm B

Experimental

Paracetamol + Ketoprofen

干预措施: Ketoprofen (Drug)

结局指标

主要结局

Level of immediate post-operative pain

时间窗: Day 1

Immediate post-operative pain will be assessed on a scale from 0 to 10. Experimental treatment will be considered as a success if the level of pain is \< 4, 4 hours after the surgical operation.

次要结局

  • Assessment of anxiety(inclusion, Days 3 and 30)
  • Level of pain linked to the operative procedure during brachytherapy and at home(Day 1 (8, 12 hours), Days 3, 15 and 30)
  • Tolerance of the analgesic treatment(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验